TSH and FT4 Reference Intervals in Pregnancy: A Systematic Review and Individual Participant Data Meta-Analysis
Open accessThe DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
CONTEXT: Interpretation of thyroid function tests during pregnancy is limited by the generalizability of reference intervals between cohorts due to inconsistent methodology. OBJECTIVE: (1) To provide an overview of published reference intervals for thyrotropin (TSH) and free thyroxine (FT4) in pregnancy, (2) to assess the consequences of common methodological between-study differences by combining raw data from different cohorts. METHODS: (1) Ovid MEDLINE, EMBASE, and Web of Science were searched until December 12, 2021. Studies were assessed in duplicate. (2) The individual participant data (IPD) meta-analysis was performed in participating cohorts in the Consortium on Thyroid and Pregnancy. RESULTS: (1) Large between-study methodological differences were identified, 11 of 102 included studies were in accordance with current guidelines; (2) 22 cohorts involving 63 198 participants were included in the meta-analysis. Not excluding thyroid peroxidase antibody-positive participants led to a rise in the upper limits of TSH in all cohorts, especially in the first (mean +17.4%; range +1.6 to +30.3%) and second trimester (mean +9.8%; range +0.6 to +32.3%). The use of the 95th percentile led to considerable changes in upper limits, varying from -10.8% to -21.8% for TSH and -1.2% to -13.2% for FT4. All other additional exclusion criteria changed reference interval cut-offs by a maximum of 3.5%. Applying these findings to the 102 studies included in the systematic review, 48 studies could be used in a clinical setting. CONCLUSION: We provide an overview of clinically relevant reference intervals for TSH and FT4 in pregnancy. The results of the meta-analysis indicate that future studies can adopt a simplified study setup without additional exclusion criteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to the aforementioned parameters, the reference interval for TSH during pregnancy varies also by trimester, fetal number, and geography (i.e., iodine intake and ethnicity) as well as the TSH assay used.”
From Thyroid Stimulating Hormone and Thyroid Hormones (Triiodothyronine and Thyroxine): An American Thyroid Association-Commissioned Review of Current Clinical and Laboratory Status (2023) · cites this paper as [55]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent meta-analyses have identified clinically relevant TSH and FT4 concentrations in pregnancy, 22 and the need for assay and trimester-specific reference ranges.23”
From Hypothyroidism (2024) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., Nixon, A., Pearce, E. N., Soldin, O. P., Sullivan, S., et al. (2011) · Thyroid · doi:10.1089/thy.2011.0087 · Cited by 2,942 · cited 2×
“Moreover, large methodological differences exist between studies as a result of new insights and changing guidelines (4, 8, 11).”
BackgroundSelf-citationAlexander, E. K., Pearce, E. N., Brent, G. A., Brown, R. S., Chen, H., Dosiou, C., Grobman, W. A., Laurberg, P., Lazarus, J. H., Mandel, S. J., et al. (2017) · Thyroid® · doi:10.1089/thy.2016.0457 · Cited by 2,731 · cited 4×
“Moreover, large methodological differences exist between studies as a result of new insights and changing guidelines (4, 8, 11).”
BackgroundMethodInfluentialSelf-citationThyroid Function and Human Reproductive Health
Krassas, G. E., Poppe, K., & Glinoer, D. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0041 · Cited by 1,223 · cited 1×
“Furthermore, there is no universal reference interval for thyrotropin (TSH) or free thyroxine (FT4) during pregnancy due to considerable differences between assays as well as population characteristics (5-7).”
BackgroundSelf-citationLaboratory Support for the Diagnosis and Monitoring of Thyroid Disease
(2003) · Thyroid · doi:10.1089/105072503321086962 · Cited by 1,212
Self-citationLazarus, J., Brown, R. S., Daumerie, C., Hubalewska-Dydejczyk, A., Negro, R., & Vaidya, B. (2014) · European Thyroid Journal · doi:10.1159/000362597 · Cited by 742 · cited 1×
“…by the American Thyroid Association (ATA), recommend the use of population-and trimester-specific TSH and FT4 reference intervals as the gold standard, calculated in a population with no known thyroid disease, optimal iodine status, and negative thyroid peroxidase antibody (TPOAb) status (4, 8, 9).”
BackgroundSelf-citationGlobal Iodine Status in 2011 and Trends over the Past Decade
Andersson, M., Karumbunathan, V., & Zimmermann, M. B. (2012) · The Journal of Nutrition · doi:10.3945/jn.111.149393 · Cited by 703 · cited 1×
“We also excluded studies in populations with severe iodine deficiency (defined as urinary iodine secretion 50 µ g/L (19)) as assessed in the cohort or, if unavailable, as reported by the WHO or regional studies (20, 21).”
MethodThyroid disease in pregnancy: new insights in diagnosis and clinical management
Korevaar, T. I. M., Medici, M., Visser, T. J., & Peeters, R. P. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.93 · Cited by 441
Self-citationThe Consortium on Thyroid and Pregnancy—Study Group on Preterm Birth, Korevaar, T. I. M., Derakhshan, A., Taylor, P. N., Meima, M., Chen, L., Bliddal, S., Carty, D. M., Meems, M., Vaidya, B., et al. (2019) · JAMA · doi:10.1001/jama.2019.10931 · Cited by 378
Self-citationAndersson, M., Takkouche, B., Egli, I. M., Allen, H., & de Benoist, B. (2005) · Europe PMC (PubMed Central) · Cited by 299
Derakhshan, A., Peeters, R. P., Taylor, P. N., Bliddal, S., Carty, D. M., Meems, M., Vaidya, B., Chen, L., Knight, B. A., Ghafoor, F., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30061-9 · Cited by 251 · cited 2×
“Thyroid function test abnormalities during pregnancy are associated with a higher risk of adverse pregnancy and child outcomes (1-4).”
BackgroundMethodSelf-citationShi, X., Han, C., Li, C., Mao, J., Wang, W., Xie, X., Li, C., Xu, B., Meng, T., Du, J., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3704 · Cited by 239 · cited 1×
“On the other hand, chronic excessive iodine intake may lead to hypothyroidism, while a sudden increase in iodine intake may lead to transient hyperthyroidism (25).”
BackgroundOzarda, Y., Sikaris, K., Streichert, T., Macri, J., & on behalf of IFCC Committee on Reference intervals and Decision Limits (C-RIDL) (2018) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2018.1482256 · Cited by 212 · cited 2×
“Some studies define reference intervals by the 5th and 95th percentiles, whereas in routine laboratory practice, the 2.5th to 97.5th percentiles are typically used (18).”
MethodAutoimmune thyroid disease during pregnancy
De Leo, S., & Pearce, E. N. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30402-3 · Cited by 211 · cited 1×
“Between the cohorts in this study, 3% to 18% of all participants are TPOAb-positive, which is associated with an impaired thyroidal response to human chorionic gonadotropin stimulation and a higher risk of adverse pregnancy outcomes (27-29).”
BackgroundSelf-citationDong, A. C., & Stagnaro-Green, A. (2019) · Thyroid · doi:10.1089/thy.2018.0475 · Cited by 202 · cited 1×
“…of using a fixed upper limit for TSH may lead to considerable under-and overdiagnosis compared with the gold standard because of interpopulation and interassay differences (10), the method of subtracting an absolute number from the nonpregnancy reference interval has not been thoroughly researched.”
MethodPearce, E. N. (2012) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e328355cd6c · Cited by 175 · cited 1×
“While a higher BMI is positively associated with TSH, and negatively with FT4 in nonpregnant individuals (35), the re-sults in pregnancy are inconclusive (36-38), and the effect of excluding obese participants for calculating reference intervals is largely unknown.”
BackgroundSelf-citationThe Adverse Effects of Mild-to-Moderate Iodine Deficiency during Pregnancy and Childhood: A Review
Zimmermann, M. B. (2007) · Thyroid · doi:10.1089/thy.2007.0108 · Cited by 162 · cited 1×
“We also excluded studies in populations with severe iodine deficiency (defined as urinary iodine secretion <50 μg/L (19)) as assessed in the cohort or, if unavailable, as reported by the WHO or regional studies (20, 21).”
MethodDiagnosis and management of subclinical hypothyroidism in pregnancy
Negro, R., & Stagnaro-Green, A. (2014) · BMJ · doi:10.1136/bmj.g4929 · Cited by 158 · cited 6×
“above: (1) without excluding TPOAb-positive participants, (2) using the 5th to 95th percentiles, and using additional exclusion criteria defined as (3) prepregnancy diabetes mellitus, (4) essential hypertension, (5) obesity, defined as a BMI > 30 kg/m2 at time of the first study visit, (6) active smoking, (7) concepti…”
BackgroundMethodResultInfluentialEthnic differences in maternal thyroid parameters during pregnancy: the Generation R study
Korevaar, T. I. M., Medici, M., de Rijke, Y. B., Visser, W., de Muinck Keizer-Schrama, S. M. P. F., Jaddoe, V. W. V., Hofman, A., Ross, H. A., Visser, W. E., Hooijkaas, H., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2005 · Cited by 150
Self-citationMännistö, T., Surcel, H.-M., Ruokonen, A., Vääräsmäki, M., Pouta, A., Bloigu, A., Järvelin, M.-R., Hartikainen, A.-L., & Suvanto, E. (2011) · Thyroid · doi:10.1089/thy.2010.0337 · Cited by 147 · cited 2×
“Two cohort studies from Finland and China demonstrated a positive correlation between BMI and TSH in pregnancy (16, 38); however, while a higher BMI was associated with a higher upper limit of TSH in the Finnish cohort, in the Chinese cohort a higher BMI was associated with a lower reference limit…”
BackgroundSelf-citationKorevaar, T. I. M., Steegers, E. A. P., Pop, V. J. M., Broeren, M. A. C., Chaker, L., de Rijke, Y. B., Jaddoe, V. W. V., Medici, M., Visser, T. J., Tiemeier, H. W., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2942 · Cited by 145 · cited 1×
“Between the cohorts in this study, 3% to 18% of all participants are TPOAb-positive, which is associated with an impaired thyroidal response to human chorionic gonadotropin stimulation and a higher risk of adverse pregnancy outcomes (27-29).”
BackgroundSelf-citationThyroid function characteristics and determinants: the Rotterdam study.
Chaker, L., Korevaar, T. I. M., Medici, M., Uitterlinden, A. G., Hofman, A., Dehghan, A., Franco, O. H., & Peeters, R. P. (2016) · Thyroid · doi:10.1089/thy.2016.0133 · Cited by 118 · cited 1×
“This is despite opposite results in some single-center studies and considering that most factors are known determinants of mean TSH and/or FT4 concentrations in a nonpregnant population (34).”
ResultSelf-citationHe, X., Wang, P., Wang, Z., He, X., Xu, D., & Wang, B. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0379 · Cited by 106 · cited 1×
“Studies on the risk of adverse pregnancy outcomes in TgAb-positive women have been inconsistent (30-32), but the Addi onal exclusions Gold standard(2) 10 (17.”
ResultTPO antibody positivity and adverse pregnancy outcomes
Dhillon‐Smith, R. K., & Coomarasamy, A. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101433 · Cited by 95
Abel, M. H., Korevaar, T. I. M., Erlund, I., Villanger, G. D., Caspersen, I. H., Arohonka, P., Alexander, J., Meltzer, H. M., & Brantsæter, A. L. (2018) · Thyroid · doi:10.1089/thy.2018.0305 · Cited by 93 · cited 2×
“Mild-to-moderate iodine deficiency (50-149 µ g/L) was not a criterion for exclusion, since TSH and FT4 reference intervals do not meaningfully differ from iodine-sufficient reference intervals (22, 23).”
BackgroundSelf-citationThyroid Autoimmunity and Recurrent Miscarriage
Ticconi, C., Giuliani, E., Veglia, M., Pietropolli, A., Piccione, E., & Simone, N. D. (2011) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2011.01021.x · Cited by 75 · cited 1×
“Studies on the risk of adverse pregnancy outcomes in TgAb-positive women have been inconsistent (30-32), but the Addi onal exclusions Gold standard(2) 10 (17.”
ResultPop, V. J., Biondi, B., Wijnen, H. A., Kuppens, S. M., & LVader, H. (2013) · Clinical Endocrinology · doi:10.1111/cen.12177 · Cited by 63 · cited 1×
“While a higher BMI is positively associated with TSH, and negatively with FT4 in nonpregnant individuals (35), the re-sults in pregnancy are inconclusive (36-38), and the effect of excluding obese participants for calculating reference intervals is largely unknown.”
BackgroundSelf-citationThe Role of Human Chorionic Gonadotropin as a Thyroid Stimulator in Normal Pregnancy
Hershman, J. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1461 · Cited by 54 · cited 1×
“Furthermore, there is no universal reference interval for thyrotropin (TSH) or free thyroxine (FT4) during pregnancy due to considerable differences between assays as well as population characteristics (5-7).”
BackgroundBliddal, S., Derakhshan, A., Xiao, Y., Chen, L., Männistö, T. I., Ashoor, G., Tao, F., Brown, S. J., Vafeiadi, M., Itoh, S., et al. (2022) · Thyroid · doi:10.1089/thy.2022.0083 · Cited by 46 · cited 1×
“…was further established in a recent study by the Consortium on Thyroid and Pregnancy wherein TPOAbs were shown to have a stronger association with higher TSH concentrations than TgAbs, and where the association with TgAb concentrations lost significance when adjusting for TPOAb concentration (33).”
BackgroundSelf-citationReference Ranges and Determinants of Thyroid Function During Early Pregnancy: The SELMA Study
Derakhshan, A., Shu, H., Broeren, M. A. C., de Poortere, R. A., Wikström, S., Peeters, R. P., DEMENEIX, B. A., Bornehag, C., & Korevaar, T. I. M. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00890 · Cited by 44 · cited 2×
“Although some of these factors are determinants of TSH and FT4 concentrations, only some, but not all, studies show that exclusion of women according to these determinants affects TSH and FT4 reference intervals (12-17).”
BackgroundResultSelf-citationHou, Y., Liu, A., Li, J., Wang, H., Yang, Y., Li, Y., Fan, C., Zhang, H., Wang, H., Ding, S., et al. (2019) · Thyroid · doi:10.1089/thy.2018.0097 · Cited by 43 · cited 1×
“Studies on the risk of adverse pregnancy outcomes in TgAb-positive women have been inconsistent (30-32), but the Addi onal exclusions Gold standard(2) 10 (17.”
ResultEarly pregnancy thyroid hormone reference ranges in Chilean women: the influence of body mass index
Mosso, L. M., Martínez, A., Rojas, M. P., Latorre, G., Margozzini, P., Lyng, T., Jorge Carvajal, C., Campusano, C., Arteaga, E., & Boucai, L. (2016) · Clinical Endocrinology · doi:10.1111/cen.13127 · Cited by 39 · cited 1×
“according to these determinants affects TSH and FT4 reference intervals (12-17).”
BackgroundSelf-citationVeltri, F., Belhomme, J., Kleynen, P., Grabczan, L., Rozenberg, S., Pepersack, T., & Poppe, K. G. (2017) · Clinical Endocrinology · doi:10.1111/cen.13340 · Cited by 37
Self-citationHaddow, J. E., Craig, W. Y., Palomaki, G. E., Neveux, L. M., Lambert-Messerlian, G. M., Canick, J. A., Malone, F. D., & Tr, M. E. D. F. T. F. A. S. (2012) · Thyroid · doi:10.1089/thy.2012.0440 · Cited by 33 · cited 1×
“While a higher BMI is positively associated with TSH, and negatively with FT4 in nonpregnant individuals (35), the results in pregnancy are inconclusive (36-38), and the effect of excluding obese participants for calculating reference intervals is largely unknown.”
BackgroundSelf-citationLevie, D., Derakhshan, A., Shu, H., Broeren, M. A. C., de Poortere, R. A., Peeters, R. P., Bornehag, C., DEMENEIX, B. A., & Korevaar, T. I. M. (2019) · Thyroid · doi:10.1089/thy.2019.0164 · Cited by 30 · cited 2×
“Mild-to-moderate iodine deficiency (50-149 µ g/L) was not a criterion for exclusion, since TSH and FT4 reference intervals do not meaningfully differ from iodine-sufficient reference intervals (22, 23).”
Self-citationMaternal adiposity, smoking, and thyroid function in early pregnancy
Andersen, S. L., Knøsgaard, L., Handberg, A., Vestergaard, P., & Andersen, S. (2021) · Endocrine Connections · doi:10.1530/ec-21-0376 · Cited by 18 · cited 1×
“according to these determinants affects TSH and FT4 reference intervals (12-17).”
BackgroundSheng, Y., Huang, D., Liu, S., Guo, X., Chen, J., Shao, Y., Zhang, G.-Q., Wei, L., Zeng, X., & Qiu, X. (2018) · BioMed Research International · doi:10.1155/2018/2032413 · Cited by 15 · cited 1×
“Two cohort studies from Finland and China demonstrated a positive correlation between BMI and TSH in pregnancy (16, 38); however, while a higher BMI was associated with a higher upper limit of TSH in the Finnish cohort, in the Chinese cohort a higher BMI was associated with a lower reference limit…”
Background[Iodine nutrition in school children of four census areas of Chile].
MUZZO, S., Burgueño, M. J., Carvajal, F., Biolley, E., Avendaño, M., Vargas, S., & Leiva, L. (1997) · PubMed · Cited by 3
Cited by
Taylor, P. N., Medici, M. M., Hubalewska-Dydejczyk, A., & Boelaert, K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01614-3 · Cited by 128
Self-citationChaker, L., Cooper, D. S., Walsh, J. P., & Peeters, R. P. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02016-0 · Cited by 174
Self-citationVan Uytfanghe, K., Ehrenkranz, J., Halsall, D., Hoff, K., Loh, T. P., Spencer, C. A., Köhrle, J., & ATA Thyroid Function Tests Writing Group (2023) · Thyroid® · doi:10.1089/thy.2023.0169 · Cited by 100
“54,55 TSH is lowest in the first trimester, lower in women with twins than in women with singleton pregnancies, is * 0.4 mIU/L lower in African and Asian women, and is higher in women with insufficient iodine intake.”
BackgroundInfluentialHypothyroidism: The difficulty in attributing symptoms to their underlying cause
Jansen, H. I., Boelen, A., Heijboer, A. C., Bruinstroop, E., & Fliers, E. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1130661 · Cited by 63
“Thus, optimal biochemical monitoring during TH treatment is still a matter of debate and pitfalls regarding the measurement and interpretation of TSH and FT4 should be acknowledged and taken into account by laboratory specialists and clinicians.”
BackgroundResultInfluentialConsequences of undertreatment of hypothyroidism
Feldt‐Rasmussen, U., Effraimidis, G., Bliddal, S., & Klose, M. (2023) · Endocrine · doi:10.1007/s12020-023-03460-1 · Cited by 61
“Physiologically, the maternal thyroid hormone production adapts to this situation upon the binding of the pregnancy-related hormone human chorionic gonadotropin to the TSH receptor resulting in the necessary increased thyroid hormone production [29].”
BackgroundSelf-citation
Metadata
- Authors
- Osinga, J. A. J., Derakhshan, A., Palomaki, G. E., Ashoor, G., Männistö, T., Maraka, S., Chen, L., Bliddal, S., Lu, X., Taylor, P. N., Vrijkotte, T. G. M., Tao, F.-B., Brown, S. J., Ghafoor, F., Poppe, K., Veltri, F., Chatzi, L., Vaidya, B., Broeren, M. A. C., Shields, B. M., Itoh, S., Mosso, L., Popova, P. V., Anopova, A. D., Kishi, R., Aminorroaya, A., Kianpour, M., López-Bermejo, A., Oken, E., Pirzada, A., Vafeiadi, M., Bramer, W. M., Suvanto, E., Yoshinaga, J., Huang, K., Bassols, J., Boucai, L., Feldt-Rasmussen, U., Grineva, E. N., Pearce, E. N., Alexander, E. K., Pop, V. J. M., Nelson, S. M., Walsh, J. P., Peeters, R. P., Chaker, L., Nicolaides, K. H., D’Alton, M. E., & Korevaar, T. I. M.
- Affiliations
- Erasmus MC (NL)
- Brown University (US)
- Harris Birthright Research Centre for Fetal Medicine (GB)
- Oulu University Hospital (FI)
- Mayo Clinic (US)
- Ruian People's Hospital (CN)
- University of Copenhagen (DK)
- Cardiff University (GB)
- Amsterdam Public Health (NL)
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University; Anhui Provincial Key Laboratory of Population Health & Aristogenics , Hefei, Anhui , China
- Sir Charles Gairdner Hospital (AU)
- Department of Research and Innovation, Shalamar Institute of Health Sciences , Lahore , Pakistan
- Université Libre de Bruxelles (BE)
- Department of Preventive Medicine, Keck School of Medicine, University of Southern California , CA 90089 , USA
- University of Exeter (GB)
- Máxima Medisch Centrum (NL)
- Hokkaido University (JP)
- Pontificia Universidad Católica de Chile (CL)
- First Pavlov State Medical University of St. Petersburg (RU)
- Federal Almazov North-West Medical Research Centre (RU)
- Isfahan University of Medical Sciences (IR)
- Pediatric Endocrinology Research Group, Girona Biomedical Research Institute (IDIBGI), Dr. Josep Trueta Hospital , Girona , Spain
- Harvard University (US)
- Shifa International Hospital (PK)
- University of Crete (GR)
- University of Oulu (FI)
- Toyo University (JP)
- Anhui Medical University (CN)
- Institut d'Investigació Biomèdica de Girona (ES)
- Memorial Sloan Kettering Cancer Center (US)
- Department of Medical Endocrinology and Metabolism, Copenhagen University Hospital, Rigshospitalet, and Department of Clinical Medicine, Faculty of Health and clinical Sciences, Copenhagen University , Copenhagen , Denmark
- Boston University (US)
- Brigham and Women's Hospital (US)
- Tilburg University (NL)
- University of Glasgow (GB)
- The University of Western Australia (AU)
- King's College London (GB)
- Columbia University Irving Medical Center (US)
- Corresponding author
- Osinga, Joris A J
- ORCID
- Osinga, Joris A J
- Derakhshan, Arash
- Palomaki, Glenn E
- Männistö, Tuija
- Maraka, Spyridoula
- Chen, Liangmiao
- Bliddal, Sofie
- Lu, Xuemian
- Taylor, Peter N
- Vrijkotte, Tanja G M
- Brown, Suzanne J
- Poppe, Kris
- Vaidya, Bijay
- Shields, Beverley M
- Mosso, Lorena
- Popova, Polina V
- Anopova, Anna D
- Kishi, Reiko
- Aminorroaya, Ashraf
- Kianpour, Maryam
- López-Bermejo, Abel
- Oken, Emily
- Vafeiadi, Marina
- Bramer, Wichor M
- Yoshinaga, Jun
- Huang, Kun
- Bassols, Judit
- Boucai, Laura
- Feldt-Rasmussen, Ulla
- Grineva, Elena N
- Pearce, Elizabeth N
- Alexander, Erik K
- Pop, Victor J M
- Nelson, Scott M
- Walsh, John P
- Peeters, Robin P
- Chaker, Layal
- Nicolaides, Kypros H
- D’Alton, Mary E
- Korevaar, Tim I M
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2022-07-21
- Volume
- 107
- Issue
- 10
- Pages
- 2925-2933
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC9516198
- OpenAlex
- W4286491818
- Cited by
- 54
- References
- 38
- Citations by year
- 2026: 13 · 2025: 14 · 2024: 12 · 2023: 13 · 2022: 2
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc-nd)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by-nc-nd)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, cc-by-nc-nd)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- UWA Profiles and Research Repository (UWA) (submittedVersion, cc-by-nc-nd)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion, public-domain)
- Funders
- Netherlands Organization for Scientific Research (grant 401.16.020)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- thyroid-stimulating hormone, free thyroxine, thyroid function tests, pregnancy, reference values, thyroid peroxidase antibodies, methodological heterogeneity, thyroid function in pregnancy
- MeSH terms
- Female, Humans, Iodide Peroxidase, Pregnancy, Reference Values, Thyroid Function Tests, Thyroid Gland, Thyrotropin, Thyroxine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.